That has presented a "clear and present danger" that strains of P falciparum and other malaria parasites may emerge that are resistant to all current drugs. "These results are definitely good news ...
Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...